Boston Scientific Corporation (BSX)
BSX Price and Sentiment
BSX Latest news
Boston Scientific Announces Upcoming Conference Schedule
2021-11-08 09:30MARLBOROUGH, Mass., Nov. 8, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.
QIPT vs. BSX: Which Stock Should Value Investors Buy Now?
2021-10-29 12:59QIPT vs. BSX: Which Stock Is the Better Value Option?
4 Medical Products Stocks Poised to Beat This Earnings Season
2021-10-28 12:13Amid concerns surrounding growing COVID-19 cases affecting the medical products companies' legacy business, we are optimistic about IDXX, HSIC, CGC and PODD's results this time around.
Boston Scientific Corporation (BSX) CEO Mike Mahoney on Q3 2021 Results - Earnings Call Transcript
2021-10-27 12:22Boston Scientific Corporation (BSX) CEO Mike Mahoney on Q3 2021 Results - Earnings Call Transcript
Boston Scientific (BSX) Q3 Earnings Top Estimates, Margins Up
2021-10-27 12:11Barring CRM, Boston Scientific's (BSX) organic revenues at each of its core business segments and geographies increase in Q3.
Boston Scientific Q3 Earnings Comes Inline With Wall Street Expectations
2021-10-27 09:17Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.93 billion in Q3 of 2021, almost in line with the Wall Street estimate of $2.97 billion. Sales increased 10.3% Y/Y on a reported basis and 10.6% on an organic basis, lower than the Company's guidance of 12% - 14%.
Boston Scientific (BSX) Q3 Earnings Beat Estimates
2021-10-27 09:05Boston Scientific (BSX) delivered earnings and revenue surprises of 2.50% and -1.61%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Boston Scientific Q3 Earnings
2021-10-27 07:20Boston Scientific (NYSE:BSX) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:30 AM. Here's what investors need to know about the announcement.
Boston Scientific stock gains after profit tops expectations, while sales came up a bit short
2021-10-27 06:44Shares of Boston Scientific Corp. BSX, -0.38% rose 0.4% in premarket trading Wednesday, after the medical device company reported third-quarter profit that topped expectations, but sales that came up a bit shy, while nudging up its earnings outlook and cutting its sales growth view. The company swung to net income of $405 million, or 28 cents a share, from a loss of $169 million, or 12 cents a share, in the year-ago period.
Boston Scientific Announces Results For Third Quarter 2021
2021-10-27 06:30MARLBOROUGH, Mass., Oct. 27, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.932 billion during the third quarter of 2021, growing 10.3 percent on a reported basis, 9.7 percent on an operational1 basis and 10.6 percent on an organic2 basis, all compared to the prior year period.